Robeco Institutional Asset Management B.V. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Robeco Institutional Asset Management B.V. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$557,487
+22.4%
20,4620.0%0.00%0.0%
Q2 2023$455,280
-32.8%
20,462
-34.5%
0.00%
-50.0%
Q1 2023$677,070
+6.6%
31,2590.0%0.00%0.0%
Q4 2022$634,870
+1.4%
31,259
+27.8%
0.00%0.0%
Q3 2022$626,000
-9.1%
24,450
-15.6%
0.00%0.0%
Q2 2022$689,000
+6.8%
28,962
+1.0%
0.00%0.0%
Q1 2022$645,000
+13.8%
28,6710.0%0.00%
+100.0%
Q4 2021$567,000
+0.5%
28,6710.0%0.00%0.0%
Q3 2021$564,000
-10.6%
28,6710.0%0.00%0.0%
Q2 2021$631,000
-32.3%
28,671
-26.8%
0.00%
-50.0%
Q1 2021$932,000
-28.4%
39,182
-21.3%
0.00%
-33.3%
Q4 2020$1,301,000
+32.6%
49,778
-11.6%
0.00%0.0%
Q3 2020$981,000
+33.3%
56,291
+28.7%
0.00%
+50.0%
Q2 2020$736,000
+41.5%
43,7530.0%0.00%0.0%
Q1 2020$520,000
+95.5%
43,753
+99.1%
0.00%
+100.0%
Q4 2019$266,000
-14.2%
21,9710.0%0.00%0.0%
Q3 2019$310,000
+6.9%
21,971
+24.7%
0.00%0.0%
Q1 2018$290,000
-8.8%
17,6240.0%0.00%
-50.0%
Q4 2017$318,000
-6.5%
17,6240.0%0.00%0.0%
Q3 2017$340,000
+63.5%
17,6240.0%0.00%
+100.0%
Q2 2017$208,00017,6240.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders